Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Apostolia Maria Tsimberidou; Jorge Medina; Jorge Cortes; Adan Rios; Glisson Bonnie; Stefan Faderl; Hagop Kantarjian; Guillermo Garcia-Manero

doi:10.1016/j.leukres.2003.10.020

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Apostolia Maria Tsimberidou
, Jorge Medina
, Jorge Cortes
, Adan Rios
, Glisson Bonnie
, Stefan Faderl
, Hagop Kantarjian
, Guillermo Garcia-Manero

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

Original language	English (US)
Pages (from-to)	657-660
Number of pages	4
Journal	Leukemia Research
Volume	28
Issue number	6
DOIs	https://doi.org/10.1016/j.leukres.2003.10.020
State	Published - Jun 2004
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Acquired immune deficiency syndrome
Chronic myeloid leukemia
Imatinib mesylate

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2003.10.020

Cite this

Tsimberidou, A. M., Medina, J., Cortes, J., Rios, A., Bonnie, G., Faderl, S., Kantarjian, H., & Garcia-Manero, G. (2004). Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature. Leukemia Research, 28(6), 657-660. https://doi.org/10.1016/j.leukres.2003.10.020

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature. / Tsimberidou, Apostolia Maria; Medina, Jorge; Cortes, Jorge et al.
In: Leukemia Research, Vol. 28, No. 6, 06.2004, p. 657-660.

Research output: Contribution to journal › Article › peer-review

Tsimberidou, AM, Medina, J, Cortes, J, Rios, A, Bonnie, G, Faderl, S, Kantarjian, H & Garcia-Manero, G 2004, 'Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature', Leukemia Research, vol. 28, no. 6, pp. 657-660. https://doi.org/10.1016/j.leukres.2003.10.020

@article{243b94faf14a48a5b3c0d970a6f47f76,

title = "Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature",

abstract = "We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.",

keywords = "Acquired immune deficiency syndrome, Chronic myeloid leukemia, Imatinib mesylate",

author = "Tsimberidou, \{Apostolia Maria\} and Jorge Medina and Jorge Cortes and Adan Rios and Glisson Bonnie and Stefan Faderl and Hagop Kantarjian and Guillermo Garcia-Manero",

year = "2004",

month = jun,

doi = "10.1016/j.leukres.2003.10.020",

language = "English (US)",

volume = "28",

pages = "657--660",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome

T2 - Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

AU - Tsimberidou, Apostolia Maria

AU - Medina, Jorge

AU - Cortes, Jorge

AU - Rios, Adan

AU - Bonnie, Glisson

AU - Faderl, Stefan

AU - Kantarjian, Hagop

AU - Garcia-Manero, Guillermo

PY - 2004/6

Y1 - 2004/6

N2 - We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

AB - We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

KW - Acquired immune deficiency syndrome

KW - Chronic myeloid leukemia

KW - Imatinib mesylate

UR - https://www.scopus.com/pages/publications/2142768442

UR - https://www.scopus.com/pages/publications/2142768442#tab=citedBy

U2 - 10.1016/j.leukres.2003.10.020

DO - 10.1016/j.leukres.2003.10.020

M3 - Article

C2 - 15120945

AN - SCOPUS:2142768442

SN - 0145-2126

VL - 28

SP - 657

EP - 660

JO - Leukemia Research

JF - Leukemia Research

IS - 6

ER -

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this